Treatment of advanced non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British medical journal

• Publication date

  2002-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.325.7362.452PMID 12202311PMCID PMC1123980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial

  2002cited by this paper
• Palliative radiotherapy regimens for non-small cell lung cancer.

  2001cited by this paper
• Managing poor performance non-small-cell lung cancer patients.

  2001cited by this paper
• Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

  2000cited by this paper
• Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

  2000cited by this paper
• Non-small-cell lung cancer--stalemate or progress?

  2000cited by this paper
• Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

  2000cited by this paper
• Chemotherapy for non-small cell lung cancer.

  2000cited by this paper
• Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer

  1996cited by this paper
• Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta‐analysis

  1996cited by this paper
• Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta‐analysis

  1996cited by this paper
• Chemotherapy for non-small cell lung cancer

  1995cited by this paper
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis.

  1993cited by this paper

• The story behind the curtains: Life of a caregiver

  2024cites this paper
• The mighty minions of non-small-cell lung cancer: EGFR, ALK, and ROS1

  2024cites this paper
• Gefitinib triumphs: Long-term advantages over chemotherapy in the treatment of EGFR mutant lung cancer

  2024cites this paper
• Phase III randomized controlled trial of gefitinib versus chemotherapy in EGFR-positive treatment-naïve metastatic lung cancer: Long-term outcome after eight years

  2024cites this paper
• Charting my course: From challenges to compassion in my oncology odyssey

  2024cites this paper
• Molecular analysis for EGFR, ALK, and ROS1 alterations in over 3000 Indian patients with non-small-cell lung cancer: A retrospective observational study

  2024cites this paper
• Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis

  2022cites this paper
• Lung cancer with dual EGFR and ALK driver alterations at baseline: a retrospective observational cohort study

  2022cites this paper
• MET: A narrative review of exon 14 skipping mutation in non-small-cell lung carcinoma

  2022cites this paper
• Ramucirumab in Stage IV non-small-cell lung cancer: Indian data

  2022cites this paper
• Does REVEL reveal an attractive option after platinum failure in advanced non-small-cell lung cancer in the Indian population?

  2022cites this paper
• Pembrolizumab Weight-Based Dosing: Conviction and Lacunae in Adopting a Cost-Saving Approach—A Survey Report

  2022cites this paper
• Detect the early-warning signals of diseases based on signaling pathway perturbations on a single sample

  2021cites this paper
• Concurrent EGFR and PIK3CA mutations in non-small-cell lung cancer

  2021cites this paper
• The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines

  2021cites this paper
• Genotype-Guided Radiomics Signatures for Recurrence Prediction of Non-Small Cell Lung Cancer

  2021cites this paper
• Authors' reply to Rajappa

  2021cites this paper
• Advanced lung cancer: The scope(s) of the pulmonologist!

  2021cites this paper
• Systemic Immune-inflammation Index is the Best Prognostic Factor in Patients with Advanced Stage Adenocarcinoma of the Lung Treated with Pemetrexed.

  2020cites this paper
• OTT_A_202081 3609..3617

  2019cites this paper
• Clinicopathological and prognostic signi fi cance of Nanog expression in non-small cell lung cancer : a meta-analysis

  2019cites this paper
• Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients

  2019cites this paper
• Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers

  2018cites this paper
• Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer.

  2018cites this paper
• Ginsenoside Rg 3 promotes the antitumor activity of gefitinib in lung cancer cell lines

  2018cites this paper
• Effect of Lung Cancer Treatment on Health-Related Quality of Life

  2018influential citation
• Systematic review and meta-analysis of third-line salvage therapy for the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

  2018cites this paper
• Cisplatin-Gemcitabine Related Cardiomyopathy in Non-Small Cell Lung Cancer NSCLC Patient: A Case Study

  2018cites this paper
• Sensitization of Radio-Resistant Lung Cancer Cells with a B Subunit of Bacterial Cytolethal Distending Toxin from Aggregatibacter actinomycetemcomitans

  2017cites this paper
• Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy

  2017cites this paper
• Short-and long-term outcomes for patients aged ≥ 70 years undergoing video-assisted thoracoscopic surgery for non-small cell lung cancer

  2017cites this paper
• Effect of Matrine Injection Combined with First-line Chemotherapy in the Treatment of Lung Cancer: a Meta-analysis

  2017cites this paper
• Studying combined effects of chemotherapy and radiotherapy on blood cell counts in lung cancer patients

  2017cites this paper
• Lower limb lymphedema in lung adenocarcinoma: Two case reports.

  2016cites this paper
• Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies

  2016cites this paper
• High Aspect Ratio Viral Nanoparticles for Cancer Therapy

  2016cites this paper
• Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells.

  2016cites this paper
• A Retrospective, Molecular Study of EGFR and ALK Mutations in Non small cell Lung Cancer Patients -

  2016cites this paper
• BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549

  2016cites this paper
• CD 147 promotes the proliferation , invasiveness , migration and angiogenesis of human lung carcinoma cells

  2016cites this paper
• High performance liquid chromatography: Tandem mass spectrometric determination of cisplatin levels in different visceral pleura layers of rats.

  2015cites this paper
• Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells

  2015cites this paper
• Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.

  2015cites this paper
• Determination of in vitro free radical scavenging and antiproliferative effect of Pennisetum alopecuroides on cultured A549 human lung cancer cells

  2015cites this paper
• Comparison of Glasgow prognostic score and prognostic index in patients with advanced non-small cell lung cancer

  2015cites this paper
• Sensitive Genotyping of Somatic Mutations in the EGFR, KRAS, PIK3CA, BRAF Genes from NSCLC Patients Using Hydrogel Biochips

  2015cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1141 Prognosis , Prediction and Risk Assessment in the Prevention and Treatment of Non-Small Cell Lung Cancer

  2015cites this paper
• EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology.

  2015cites this paper
• Expression of beclin 1 in non‐small cell lung cancer: an immunohistochemical study

  2015cites this paper
• Enhancement of gefitinib-induced growth inhibition by Marsdenia tenacissima extract in non-small cell lung cancer cells expressing wild or mutant EGFR

  2014cites this paper
• Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib alone for senile lung adenocarcinoma patients with EGFR mutations as first-line regimen

  2014cites this paper
• Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China

  2014cites this paper
• Comparison of epidermal growth factor receptor mutations between primary tumors and lymph nodes in non-small cell lung cancer: a review and meta-analysis of published data.

  2014cites this paper
• Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy

  2014cites this paper
• Correlation study and significance of the EGFR expression in serum, lymph nodes and tumor tissue of NSCLC

  2014cites this paper
• CLINICAL USE OF HIGH-INTENSITY FOCUSED ULTRASOUND IN THE MANAGEMENT OF DIFFERENT SOLID TUMORS

  2014cites this paper
• Aloin-induced cell growth arrest, cell apoptosis, and autophagy in human non-small cell lung cancer cells

  2014cites this paper
• PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AS A THERAPEUTIC TARGET IN NSCLC

  2014cites this paper
• Radix tetrastigma hemsleyani flavone induces apoptosis in human lung carcinoma a549 cells by modulating the MAPK pathway.

  2013cites this paper
• Comparison of Two Palliative Radiotherapy Schedules for Locally Advanced Non-Small-Cell Lung Cancer ( NSCLC )

  2013cites this paper
• Bevacizumab treatment for advanced non-small cell lung cancer: A case report

  2013cites this paper
• Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.

  2012cites this paper
• Inhibitory action of chamaejasmin A against human HEP-2 epithelial cells: effect on tubulin protein

  2012cites this paper
• Ligation of CM1 enhances apoptosis of lung cancer cells through different mechanisms in conformity with EGFR mutation

  2012cites this paper
• Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo.

  2012cites this paper
• TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells

  2012cites this paper
• Palliative chemotherapy followed by consolidation radiotherapy in patients with advanced and metastatic non-small cell lung cancer not suitable for radical treatment

  2012cites this paper
• Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials.

  2012cites this paper
• blumei extract inhibits proliferation of human lung adenocarcinoma 549 cells via induction of cell cycle arrest and apoptosis

  2011cites this paper
• Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo.

  2011cites this paper
• Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

  2011cites this paper
• Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapy

  2010cites this paper
• Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.

  2010cites this paper
• Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells.

  2009cites this paper
• Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

  2007cites this paper
• Economic impact of gefitinib for refractory non-small-cell lung cancer: a Markov model-based analysis

  2007cites this paper
• Down‐regulation of IGF‐IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice

  2007cites this paper
• Qualité de vie et sujets âgés en cancérologie

  2006cites this paper
• Patterns of Care for Non-Small Cell Lung Cancer Treatment -The Impact of Increased Consultant Site Specialisation; Quality vs Availability

  2006cites this paper
• A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)

  2005cites this paper
• Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer

  2005cites this paper
• A Phase II trial of 6-Hydroxymethylacylfulvene (MGI-114, Irofulven) in Patients with Advanced Non-Small Cell Cancer Previously Treated with Chemotherapy

  2004cites this paper
• Paliatywna radioterapia chorych na raka płuca Palliative radiotherapy in lung cancer

  2004cites this paper
• A phase II trial of a differentiating agent (tRA) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancer

  2004cites this paper
• Quality-of-life trials in lung cancer: past achievements and future challenges.

  2004cites this paper
• Genetic Vaccines and Therapy

  2003cites this paper
• Le cancer du poumon non à petites cellules : d’hier à aujourd’hui

  2002cites this paper
• An update on management of lung cancer--Acta Oncologica Lecture-Västerås 21 March 2002.

  2002cites this paper
• An Update on Management of Lung Cancer

  2002cites this paper
• A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

  2001cites this paper
• Mitomycin C: a clinical update.

  2001cites this paper
• Chemotherapy versus best supportive care in stage IV non-small cell lung cancer, non metastatic to the brain.

  2001cites this paper